RaySearch Laboratories (Q1 Initial take): Softer than expected but comforting updated financial target
RaySearch came in softer than we expected on sales and EBIT (but in line with consensus EBIT). The updated financial targets should mitigate a...
86 Views
Raysearch (Q1 preview): Expectations of a sequentially softer quarter
Redeye presents its preview of RaySearch’s Q1 2026 results due on April 29.
88 Views
Raysearch: Laser Focused
Oncology software provider RaySearch ($RAYB.st) is down almost 50%, caught in the middle of the selloffs in Software and in Swedish healthcare...
103 Views
RaySearch Laboratories (Q4 Initial take): Another record quarter
RaySearch delivered a strong Q4, with record sales above consensus estimates and record EBIT, also above consensus estimates. We expect the share...
84 Views
Raysearch (Q4 preview): Possibilities for a beaming end to 2025
Redeye presents its preview of RaySearch’s Q4 2025 results due on February 12.
85 Views